|
Status |
Public on Mar 09, 2021 |
Title |
Beat AML project [16-00056] |
Sample type |
genomic |
|
|
Source name |
Bone marrow
|
Organism |
Homo sapiens |
Characteristics |
disease state: Diagnosis tissue: Bone marrow
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Genomic DNA was isolated using column-based preparation (Qiagen)
|
Label |
Cy5 and Cy3
|
Label protocol |
Standard Illumina Protocol
|
|
|
Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium methylationEPIC using standard Illumina protocol
|
Scan protocol |
BeadArray fluorescence was measured using the Illumina iScan
|
Description |
Diagnosis bone barrow sample Bone marrow-derived genomic DNA sample obtained from the Beat AML project [16-00056]
|
Data processing |
Data were normalized by the beta mixture quantile (BMIQ) method using the RnBeads analysis software package. Beta_values.csv.gz: BMIQ normalized Average Beta Signal_Intensities.csv.gz: Unmethylated and methylated signal intensities
|
|
|
Submission date |
Oct 23, 2020 |
Last update date |
Mar 09, 2021 |
Contact name |
Christopher OAKES |
E-mail(s) |
christopher.oakes@osumc.edu
|
Phone |
6146859284
|
Organization name |
The Ohio State University
|
Street address |
400 W. 12th Avenue, Wiseman Hall, Suite 455
|
City |
Columbus |
State/province |
OH |
ZIP/Postal code |
43210 |
Country |
USA |
|
|
Platform ID |
GPL21145 |
Series (1) |
GSE159907 |
DNA methylation analysis of acute myeloid leukemia (AML) |
|